Atlas Trials

Ovarian Cancer Recurrent

27 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Cancer Recurrent

RecordFirmDate
Longitudinal Plasma Proteomic Remodeling in Ovarian Cancer (NCT07684846)University Medical Centre Ljubljana2021-10-23
Microtransplantation for Ovarian Cancer (NCT05095558)The Affiliated Hospital of the Chinese Academy of Military Medical Sciences2021-10-01
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282)Elucida Oncology2021-09-13
Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) (NCT03983226)Shanghai Gynecologic Oncology Group2019-10-18
Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer (NCT03734692)Robert Edwards2019-01-28
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors (NCT03827837)Jiangsu HengRui Medicine Co., Ltd.2019-01-23
A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer. (NCT03681548)Ayana Pharma Ltd.,2018-08-29
Adoptive T Cell Therapy in Patients With Recurrent Ovarian Cancer (NCT04072263)Leiden University Medical Center2018-08-01
The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian Cancer (NCT03162562)CanariaBio Inc.2017-05-30
EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer (NCT01485848)Esperance Pharmaceuticals Inc2012-02-01
Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel (NCT01332656)Sanofi2011-05-01
A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse (NCT01111903)ARCAGY/ GINECO GROUP2009-05-01

Track Ovarian Cancer Recurrent automatically

Every clearance here is in the API, with alerts when new ones post.